Measles/rubella double viral vaccine (Bio-Manguinhos/Fiocruz)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameMeasles/rubella double viral vaccine (Bio-Manguinhos/Fiocruz)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFundacao Oswaldo Cruz (Fiocruz)
China Registration ClassN/A
Develop Information
Active CompaniesFundacao Oswaldo Cruz (Fiocruz)
Inactive CompaniesThe Immunobiological Technology Institute
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A